Iwaki Pharmaceutical

Iwaki Pharmaceutical (Iwaki Seiyaku Co., Ltd.) is a prominent Japanese pharmaceutical company and a core subsidiary of Astena Holdings. Established in 1931, the company focuses on the development, manufacture, and commercialization of prescription drugs, OTC products, and veterinary medicines, with a specialized expertise in dermatological treatments such as topical steroids and antifungals. Iwaki operates a robust contract development and manufacturing (CDMO) business through its Sakura Factory, providing one-stop services from formulation design to commercial production for various dosage forms, including semi-solids and solids. Additionally, the company is a significant producer of active pharmaceutical ingredients (APIs) and specialty chemicals, maintaining a strong presence in the Japanese healthcare market through its commitment to high-quality generic and original formulations.